<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>Ablynx NV — New Patents | PatentBrief</title>
    <link>https://patentbrief.org/company/ablynx-nv</link>
    <description>Plain-English explanations of patents assigned to Ablynx NV, newest first.</description>
    <language>en-us</language>
    <lastBuildDate>Mon, 15 Jun 2026 05:59:48 GMT</lastBuildDate>
    <atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://patentbrief.org/company/ablynx-nv/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>How Specialized Nanobodies Block Blood Clotting Proteins</title>
      <link>https://patentbrief.org/patent/us/8372398/subcutaneous-herceptin</link>
      <description>A patent describing specific, tiny antibody fragments designed to bind to and inhibit Von Willebrand Factor, a protein that triggers blood clotting.</description>
      <pubDate>Tue, 12 Feb 2013 00:00:00 GMT</pubDate>
      <guid isPermaLink="true">https://patentbrief.org/patent/us/8372398/subcutaneous-herceptin</guid>
    </item>
  </channel>
</rss>
